Literature DB >> 25381025

Muscarinic M3 receptors on structural cells regulate cigarette smoke-induced neutrophilic airway inflammation in mice.

Loes E M Kistemaker1, Ronald P van Os2, Albertina Dethmers-Ausema2, I Sophie T Bos3, Machteld N Hylkema4, Maarten van den Berge5, Pieter S Hiemstra6, Jürgen Wess7, Herman Meurs3, Huib A M Kerstjens5, Reinoud Gosens3.   

Abstract

Anticholinergics, blocking the muscarinic M3 receptor, are effective bronchodilators for patients with chronic obstructive pulmonary disease. Recent evidence from M(3) receptor-deficient mice (M(3)R(-/-)) indicates that M3 receptors also regulate neutrophilic inflammation in response to cigarette smoke (CS). M(3) receptors are present on almost all cell types, and in this study we investigated the relative contribution of M(3) receptors on structural cells vs. inflammatory cells to CS-induced inflammation using bone marrow chimeric mice. Bone marrow chimeras (C56Bl/6 mice) were generated, and engraftment was confirmed after 10 wk. Thereafter, irradiated and nonirradiated control animals were exposed to CS or fresh air for four consecutive days. CS induced a significant increase in neutrophil numbers in nonirradiated and irradiated control animals (4- to 35-fold). Interestingly, wild-type animals receiving M(3)R(-/-) bone marrow showed a similar increase in neutrophil number (15-fold). In contrast, no increase in the number of neutrophils was observed in M3R(-/-) animals receiving wild-type bone marrow. The increase in keratinocyte-derived chemokine (KC) levels was similar in all smoke-exposed groups (2.5- to 5.0-fold). Microarray analysis revealed that fibrinogen-α and CD177, both involved in neutrophil migration, were downregulated in CS-exposed M(3)R(-/-) animals receiving wild-type bone marrow compared with CS-exposed wild-type animals, which was confirmed by RT-qPCR (1.6-2.5 fold). These findings indicate that the M(3) receptor on structural cells plays a proinflammatory role in CS-induced neutrophilic inflammation, whereas the M(3) receptor on inflammatory cells does not. This effect is probably not mediated via KC release, but may involve altered adhesion and transmigration of neutrophils via fibrinogen-α and CD177.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  anticholinergics; neutrophil adhesion; nonneuronal acetylcholine

Mesh:

Substances:

Year:  2014        PMID: 25381025      PMCID: PMC4315453          DOI: 10.1152/ajplung.00259.2014

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  27 in total

Review 1.  Chronic obstructive pulmonary disease.

Authors:  P J Barnes
Journal:  N Engl J Med       Date:  2000-07-27       Impact factor: 91.245

2.  Fibrinogen modulates leukocyte recruitment in vivo during the acute inflammatory response.

Authors:  V Vitorino de Almeida; A Silva-Herdade; A Calado; H S Rosário; C Saldanha
Journal:  Clin Hemorheol Microcirc       Date:  2015       Impact factor: 2.375

3.  Acetylcholine stimulates alveolar macrophages to release inflammatory cell chemotactic activity.

Authors:  E Sato; S Koyama; Y Okubo; K Kubo; M Sekiguchi
Journal:  Am J Physiol       Date:  1998-06

4.  Role of the parasympathetic system in airway obstruction due to emphysema.

Authors:  N J Gross; M S Skorodin
Journal:  N Engl J Med       Date:  1984-08-16       Impact factor: 91.245

Review 5.  The role of anticholinergics in chronic obstructive pulmonary disease.

Authors:  Peter J Barnes
Journal:  Am J Med       Date:  2004-12-20       Impact factor: 4.965

Review 6.  The non-neuronal cholinergic system in the airways: an unappreciated regulatory role in pulmonary inflammation?

Authors:  Catherine R Gwilt; Louise E Donnelly; Duncan F Rogers
Journal:  Pharmacol Ther       Date:  2007-05-25       Impact factor: 12.310

7.  Leukocyte engagement of fibrin(ogen) via the integrin receptor alphaMbeta2/Mac-1 is critical for host inflammatory response in vivo.

Authors:  Matthew J Flick; XinLi Du; David P Witte; Markéta Jirousková; Dmitry A Soloviev; Steven J Busuttil; Edward F Plow; Jay L Degen
Journal:  J Clin Invest       Date:  2004-06       Impact factor: 14.808

8.  The neutrophil-specific antigen CD177 is a counter-receptor for platelet endothelial cell adhesion molecule-1 (CD31).

Authors:  Ulrich J H Sachs; Cornelia L Andrei-Selmer; Amudhan Maniar; Timo Weiss; Cathy Paddock; Valeria V Orlova; Eun Young Choi; Peter J Newman; Klaus T Preissner; Triantafyllos Chavakis; Sentot Santoso
Journal:  J Biol Chem       Date:  2007-06-19       Impact factor: 5.157

9.  COPD association and repeatability of blood biomarkers in the ECLIPSE cohort.

Authors:  Jennifer A Dickens; Bruce E Miller; Lisa D Edwards; Edwin K Silverman; David A Lomas; Ruth Tal-Singer
Journal:  Respir Res       Date:  2011-11-04

Review 10.  Muscarinic receptor signaling in the pathophysiology of asthma and COPD.

Authors:  Reinoud Gosens; Johan Zaagsma; Herman Meurs; Andrew J Halayko
Journal:  Respir Res       Date:  2006-05-09
View more
  10 in total

1.  A role for muscarinic receptors in neutrophil extracellular trap formation and levamisole-induced autoimmunity.

Authors:  Carmelo Carmona-Rivera; Monica M Purmalek; Erica Moore; Meryl Waldman; Peter J Walter; H Martin Garraffo; Karran A Phillips; Kenzie L Preston; Jonathan Graf; Mariana J Kaplan; Peter C Grayson
Journal:  JCI Insight       Date:  2017-02-09

Review 2.  Cholinergic System and Its Therapeutic Importance in Inflammation and Autoimmunity.

Authors:  Namrita Halder; Girdhari Lal
Journal:  Front Immunol       Date:  2021-04-15       Impact factor: 7.561

Review 3.  Neuronal Regulation of Immunity in the Skin and Lungs.

Authors:  Kimbria J Blake; Xin Ru Jiang; Isaac M Chiu
Journal:  Trends Neurosci       Date:  2019-06-15       Impact factor: 13.837

4.  Effect of aclidinium bromide on cough and sputum symptoms in moderate-to-severe COPD in three phase III trials.

Authors:  Lorcan McGarvey; Alyn H Morice; Jaclyn A Smith; Surinder S Birring; Ferran Chuecos; Beatriz Seoane; Diana Jarreta
Journal:  BMJ Open Respir Res       Date:  2016-12-08

5.  The impact of cortisol in steatotic and non-steatotic liver surgery.

Authors:  María Eugenia Cornide-Petronio; Esther Bujaldon; Mariana Mendes-Braz; Cindy G Avalos de León; Mónica B Jiménez-Castro; Ana I Álvarez-Mercado; Jordi Gracia-Sancho; Juan Rodés; Carmen Peralta
Journal:  J Cell Mol Med       Date:  2017-04-04       Impact factor: 5.310

6.  Tiotropium bromide exerts anti-inflammatory effects during resistive breathing, an experimental model of severe airway obstruction.

Authors:  Dimitrios Toumpanakis; Konstantinos Loverdos; Vassiliki Tzouda; Vyronia Vassilakopoulou; Eleni Litsiou; Christina Magkou; Vassiliki Karavana; Michael Pieper; Theodoros Vassilakopoulos
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-07-28

7.  A transcriptomics-guided drug target discovery strategy identifies receptor ligands for lung regeneration.

Authors:  Xinhui Wu; I Sophie T Bos; Thomas M Conlon; Meshal Ansari; Vicky Verschut; Luke van der Koog; Lars A Verkleij; Angela D'Ambrosi; Aleksey Matveyenko; Herbert B Schiller; Melanie Königshoff; Martina Schmidt; Loes E M Kistemaker; Ali Önder Yildirim; Reinoud Gosens
Journal:  Sci Adv       Date:  2022-03-23       Impact factor: 14.136

Review 8.  Infection-Associated Mechanisms of Neuro-Inflammation and Neuro-Immune Crosstalk in Chronic Respiratory Diseases.

Authors:  Belinda Camp; Sabine Stegemann-Koniszewski; Jens Schreiber
Journal:  Int J Mol Sci       Date:  2021-05-27       Impact factor: 5.923

9.  Microarray analysis of lung long non-coding RNAs in cigarette smoke-exposed mouse model.

Authors:  Hao Wang; Lei Chen; Diandian Li; Ni Zeng; Yanqiu Wu; Tao Wang; Yongchun Shen; Dan Xu; Fuqiang Wen
Journal:  Oncotarget       Date:  2017-12-18

Review 10.  The protective effect of hederagenin on renal fibrosis by targeting muscarinic acetylcholine receptor.

Authors:  Wei Yang; Lijuan He
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.